Most peptide companies I talk to are building some version of the same business.
They want a large catalog. They want the compounds that are getting the most attention. They want competitive pricing, fast shipping, third-party testing, and a website that signals some combination of science and performance.
None of those things are inherently bad.
They also aren’t much of a reason to choose one company over another.
When I ask founders who they’re building for, the answer is often surprisingly broad. Researchers. People interested in longevity. People interested in performance. Men. Women. Anyone looking for high-quality peptides.
In other words: everyone who might already be shopping in the category.
That isn’t positioning. It’s a description of the available market.
A catalog is inventory. Positioning is the place you want to occupy in a customer’s mind.
The difference matters because the industry is filling up with companies offering similar products, making similar quality claims, and building nearly identical websites. Change the logo and the color palette and many of them could trade places without the customer noticing.
When businesses look interchangeable, they usually end up competing on the few differences customers can easily see: price, promotions, and who happens to have the compound they want in stock.
That can produce revenue. It doesn’t necessarily produce a durable company.
An audience you found is not the same as an audience you chose
A pattern I’ve noticed in the market is that many peptide companies appear to attract a fairly concentrated audience: often men somewhere around 55 to 65, with women representing a smaller share.
That is not a criticism of the audience. It may be a very valuable market.
What interests me is how little many companies appear to do with that information.
If older men already make up a meaningful percentage of your customers, does the business feel like it was built with them in mind?
Is the site easy to read and navigate? Does the content answer the questions they actually ask? Does the support experience reflect how they prefer to communicate? Does the company understand what creates confidence for them and what makes them suspicious?
Or did the company simply attract that demographic because those were the people already looking for the products?
There’s a meaningful difference between having an audience and understanding one.
You can see that difference throughout a business.
A company that understands its customer makes different decisions about what it sells, how it organizes the catalog, what it explains, how customer support works, what it sends by email, and where it spends money to acquire attention.
A company that doesn’t understand its customer tends to add more products.
More products can hide the harder question
Adding another product feels like progress.
It creates a new page for the website. It gives the company something to announce. It creates another search term to target and another promotion to run.
It may even produce an immediate bump in revenue.
But it can also delay a harder decision: why should this customer prefer us?
The answer cannot always be “because we carry more things.”
Someone else can add the same products. Someone else can lower the price. Someone else can copy the page.
A useful position should change more than the headline on the homepage.
Suppose a company decides to build specifically for an older, skeptical, high-information customer who values transparency and wants to understand a company before placing an order.
That decision should have consequences.
The site might prioritize readability and simple navigation over looking futuristic. Product documentation might be easier to find and understand. The company might carry fewer products but provide substantially more information about each one. Customer support might be staffed and trained differently. Emails might focus more on education and research developments and less on an endless rotation of discount codes.
None of that requires the company to make human-use claims or abandon the boundaries of the RUO category.
It requires the company to know whom it wants to serve and what that person needs from a supplier.
Another company could make a completely different choice. It might serve highly experienced buyers who want efficiency, dense technical information, reliable availability, and minimal hand-holding.
That could also be a strong position.
The point is not that every peptide company should cater to the same demographic. The point is that choosing an audience should change the company.
If your audience strategy only changes the photograph in an advertisement, you probably haven’t gone far enough.
The acquisition problem starts before the advertisement
This becomes especially obvious when a company begins spending serious money on acquisition.
An advertisement needs a reason for someone to pay attention. The page it sends people to needs a reason for them to keep reading. The business needs a reason for them to return.
If the company’s actual position is “we sell many of the same products as everyone else,” the acquisition team has very little to work with.
They can test different hooks. They can improve creative. They can change the landing page and construct a stronger offer.
But eventually the marketing runs into the business.
A good acquisition team can communicate a meaningful difference. It cannot manufacture one forever.
This is why I spend so much time asking founders about their audience before talking about ads.
Who already trusts you?
What do you understand about them that a competitor probably doesn’t?
What frustrates them about the current market?
What would you build differently if you were willing to serve them exceptionally well?
Where do they already spend attention, and what kind of message would earn rather than interrupt it?
These aren’t branding exercises. The answers affect customer acquisition costs, retention, content, service, and the products a company should carry.
The catalog should follow the position
A large catalog may ultimately be the right decision.
But the sequence matters.
If you understand the customer first, the catalog can grow around real demand. You can add products because they belong in the business you are building. You can decline products that create attention but pull the company away from the position it wants to own.
Without that discipline, the catalog tends to follow whatever is getting attention this month.
That is particularly tempting in a market experiencing gold-rush conditions. When demand is high, differentiation can feel optional. A company can make money simply by being present, carrying the right inventory, and acquiring traffic.
Gold rushes also attract more sellers. Margins tighten. Acquisition gets more expensive. The products generating the most attention can become the source of the most business risk.
When that happens, the companies with a real audience, a credible position, and a reason to exist beyond the hottest product have more options.
I don’t think every peptide company needs to become a tiny niche brand.
I do think every founder should be able to finish this sentence:
We are building this company for ________, and because we understand them, we do ________ differently.
If the honest answer is “everyone, and we have a lot of products,” the next product probably isn’t the most important thing to figure out.
I’m Shea Hoffman. I lead business development for telehealth and peptides at Lucyd. We work with serious companies building in telehealth and the research-use-only peptide market. If you’re thinking through positioning, acquisition, or what comes after the current gold rush, let’s talk.